Chairperson’s Closing Comments and Vision Statement The Evolving Therapeutic Roadmap for Atopic Dermatitis: The Foundation Role of Targeting Cytokine Signaling Systems in Patients with Moderate-to-Severe AD - Thomas Bieber, MD, PhD, MDRA – Program Chair